• A case of congenital afibrinogenemia with multiple thrombotic and hemorrhagic disorders
• A Case Report of Congenital Afibrinogenemia and Literature Review of Management of Post-circumcision Bleeding
• A Family with Congenital Dysfibrinogenemia and Blood Transfusion
• A low-dose therapy of fibrinogen supplement during perioperative period of total knee arthroplasty in an asymptomatic man with congenital dysfibrinogenemia: A case report
• A new global fibrinolysis capacity assay for the sensitive detection of hyperfibrinolysis and hypofibrinogenemia in trauma patients
• A novel FGG missense variant associated with fibrinogen storage disease in a large family from Quebec
• A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia
• A novel missense mutation (FGG c.1168G > T) in the gamma chain of fibrinogen causing congenital hypodysfibrinogenemia with bleeding phenotype
• A novel missense mutation (FGG c.1168G > T) in the gamma chain of fibrinogen causing congenital hypodysfibrinogenemia with bleeding phenotype
• A novel mutation in the FGG gene causes hypofibrinogenemia in a Chinese family
• A novel mutation in the fibrinogen γ-chain gene c.952G>T, p. (Gly318Cys) leading to hypo dysfibrinogenemia
• A single-center, retrospective analysis to compare measurement of fibrinogen using the TEG6 analyzer to the Clauss measurement in children undergoing heart surgery
• Absence of Missense Variant Detection in Inherited Dysfibrinogenemia May Result from a Poor Raw Data Analysis Algorithm or Mosaicism
• Acquired factor V and factor X Deficiency coexisting with acquired dysfibrinogenaemia in a patient with light chain myeloma
• Acute obstetric coagulopathy during postpartum hemorrhage is caused by hyperfibrinolysis and dysfibrinogenemia: an observational cohort study
• Acute pancreatitis caused by tigecycline and furosemide combination treatment and hypofibrinogenemia caused by tigecycline: A case report
• Analysis of a family with congenital hypodysfibrinogenemia presented with thrombosis
• Analysis of fibrinogen concentrate pharmacokinetics and dosing for bleeds and surgery in adults, adolescents, and children with congenital afibrinogenaemia and hypofibrinogenaemia
• Analysis of the clinical characteristics of tigecycline-induced hypofibrinogenemia
• Are all fibrinogen concentrates the same? The effects of two fibrinogen therapies in an afibrinogenemic patient and in a fibrinogen deficient plasma model. A clinical and laboratory case report
• Budd-Chiari syndrome associated with congenital afibrinogenaemia reversed after orthotopic liver transplant
• Clinical analysis of 5 cases of dermatomyositis complicated with macrophage activation syndrome
• Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia
• Clinical phenotypes and genotypes of congenital fibrinogen disorder: an analysis of 16 children
• Clinical, Laboratory, and Molecular Aspects of Congenital Fibrinogen Disorders
• Clot waveform analysis in acute promyelocytic leukemia
• Coagulopathy is an under-recognised complication of acquired HLH
• Commentary on "Novel Genetic Regulators of Fibrinogen Synthesis Identified by an In Vitro Experimental Platform"
• Comparative retrospective study on the validity of point-of-care testing device for massive obstetrical hemorrhage: dry hematology vs thromboelastography
• Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review
• Congenital Afibrinogenemia With Facial Haematoma
• Congenital fibrinogen disorders
• Congenital fibrinogen disorders-Strengthening genotype-phenotype correlations through novel genetic diagnostic tools
• Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database
• Congenital fibrinogen disorders: Strengthening genotype-phenotype correlations through novel genetic diagnostic tools
• Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients
• Dental management of a 4-year-old child with congenital afibrinogenemia-A rare case report
• Diagnostic Tests for Hypofibrinogenemia Resulting from Green Pit Viper (Trimeresurus albolabris) Envenomation: A Simulated In Vitro Study
• Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies
• Diagnostic value of clot formation parameters determined by rotational thromboelastometry in 63 patients with congenital dysfibrinogenemia
• Disseminated Intravascular Coagulation Score Predicts Mortality in Patients with Liver Disease and Low Fibrinogen Level
• Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen
• Early Diagnosis and Management of Congenital Afibrinogenemia: A Case Report of Umbilical Stump Bleeding
• Effect of low fibrinogen level on in-hospital mortality and 6-month functional outcome of TBI patients, a single center experience
• Effectiveness of Administration of Fibrinogen Concentrate as Prevention of Hypofibrinogenemia in Patients with Traumatic Brain Injury with a Higher Risk for Severe Hyperfibrinolysis: Single Center Before-and-After Study
• Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA-02 and FORMA-04 clinical trials
• Elimination of fibrin polymer formation or crosslinking, but not fibrinogen deficiency, is protective against diet-induced obesity and associated pathologies
• Envenomation by Eyelash Viper <em>Bothriechis schlegelii</em> (Berthold, 1846) in Southwestern Colombia
• Etiology and management of hypofibrinogenemia in trauma
• Evaluation of fibrinogen concentration by clot firmness using a dielectric blood coagulation test system
• Fibrinogen Aalpha gene genotyping in patients with inherited afibrinogenemia deficiency; a novel mutation in Iranian afibrinogenemia patients
• Fibrinogen Aα gene genotyping in patients with inherited afibrinogenemia deficiency; a novel mutation in Iranian afibrinogenemia patients
• Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis
• Fibrinogenolysis in Venom-Induced Consumption Coagulopathy after <em>Viperidae</em> Snakebites: A Pilot Study
• Genetic analysis of a Chinese pedigree affected with Congenital dysfibrinogenemia due to variant of FGG gene
• Genetic analysis of two Chinese pedigrees affected with Hereditary hypofibrinemia due to missense variants
• Guideline for diagnosis and management of congenital dysfibrinogenemia
• High incidence of intracranial haemorrhage in Egyptian children with congenital afibrinogenaemia
• Hypofibrinogenemia is an independent predictor of hemophagocytic lymphohistiocytosis in children with sepsis
• Hypofibrinogenemic Massive Transfusion Trauma Patients Experience Worse Outcomes
• Incidence, clinical features, and risk factors of hemocoagulase-induced hypofibrinogenemia: A retrospective real-world study
• Interest in the new thromboelastometry device, Clot Pro®, for predicting thrombocytopenia and hypofibrinogenemia during lung transplantation
• Long-Term Safety Analysis of a Fibrinogen Concentrate (RiaSTAP^®/Haemocomplettan^® P)
• Management and outcomes of women with low fibrinogen concentration during pregnancy or immediately postpartum: A UK national population-based cohort study
• Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen
• Miliary tuberculosis-associated hemophagocytic lymphohistiocytosis with a high level of soluble interleukin-2 receptor successfully treated with concomitant recombinant thrombomodulin: A case report
• Misdiagnosis of a patient with congenital dysfibrinogenemia: A case report and literature review
• Nomogram for the prediction of tigecycline-induced hypofibrinogenaemia in a Chinese population
• Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study
• One Hundred Years of Congenital Fibrinogen Disorders
• Oral surgery in people with inherited bleeding disorder: A retrospective study
• Overestimation of fibrinogen concentration in cryoprecipitate by repeated freeze-thawing with long thawing period as used in the Clauss method
• Overt Disseminated Intravascular Coagulation with Severe Hypofibrinogenemia During Veno-Venous Extracorporeal Membrane Oxygenation
• Pharmacokinetics, efficacy and safety of a novel fibrinogen concentrate in pediatric patients with congenital afibrinogenemia
• Phenotype and genotype analyses of two pedigrees with inherited fibrinogen deficiency
• Physiological correction of hereditary mild hypofibrinogenemia during pregnancy
• Placenta accreta spectrum conservative management and coagulopathy: case series and systematic review
• Placenta percreta management in a patient with a severe congenital hypofibrinogenemia
• Population pharmacokinetic modelling of fibrinogen in patients with congenital or acquired-chronic or acute-hypofibrinogenaemia
• Postoperative Prognostic Nutritional Index and Fibrinogen Could Well Predict Poor Prognosis of Acute Type A Aortic Dissection Patients After Surgery
• Prediction of hypofibrinogenaemia based on the starting fibrinogen and extent of haemodilution during cardiac surgery
• Predictive factors for severe placental damage in pregnant women with SARS-CoV-2 infection
• Preeclampsia complicated with hypofibrinogenemia: 2 case reports and review of the literature
• Prospective, Randomized Study of Fibrinogen Concentrate Versus Cryoprecipitate for Correcting Hypofibrinogenemia in Cardiac Surgery Patients
• Rare bleeding disorders: Advances in management
• Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study
• Serum concentration as a predictor of tigecycline-induced hypofibrinogenemia in critically ill patients: A retrospective cohort study
• The FIBTEM paradox: Do coronary artery bypass grafting patients with high baseline FIBTEM clot firmness need more allogeneic blood transfusion?
• The nature and timing of coagulation dysfunction in a cohort of trauma patients in the Australian pre-hospital setting
• The prevalence and risk factors of coagulopathy in pediatric patients undergoing surgery for epilepsy
• The qLabs® FIB system, a novel point-of-care technology for a rapid and accurate quantification of functional fibrinogen concentration from a single drop of citrated whole blood
• The Role of Thromboelastography during the Management of Postpartum Hemorrhage: Background, Evidence, and Practical Application
• Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study
• Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
• Transfusion of fibrinogen concentrate before dental extractions in patients with afibrinogenemia: a narrative review supported by a case report with a proposed treatment protocol
• Treatment of Congenital Afibrinogenemia in a Neonate With Critical Pulmonary Stenosis
• Two Novel Heterozygous Mutations (p.γPhe230Val and p.AαAsn839Thr) Cause Hereditary Hypodysfibrinogenemia in Two Chinese Independent Families
• Ultramassive Transfusion for Trauma in the Age of Hemostatic Resuscitation: A Retrospective Single-Center Cohort From a Large US Level-1 Trauma Center, 2011-2021
• Variants leading to dysfibrinogenaemia in the fibrinogen α-chain at residue Arg19 are not solely associated with bleeding, but also with thrombotic events
• Variants leading to dysfibrinogenaemia in the fibrinogen α-chain at residue Arg19 are not solely associated with bleeding, but also with thrombotic events-RESPONSE